Piperacillin-tazobactam
Piperacillin-tazobactam is a pharmaceutical drug with 52 clinical trials. Currently 8 active trials ongoing. Historical success rate of 72.7%.
Success Metrics
Based on 24 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
9
Mid Stage
24
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
24 of 36 finished
33.3%
12 ended early
8
trials recruiting
52
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Aminoglycosides in Early Sepsis
Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Clinical Trials (52)
Aminoglycosides in Early Sepsis
Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis
Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea
PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
eXtended Antibiotic Prophylaxis for Intermediate- and High-risk Glands After Pancreatoduodenectomy to Reduce CR-POPF
Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers.
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients
Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis.
Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)
Targeted AntiBiotics for Chronic Pulmonary Diseases
Ultra Low Doses of Therapy With Radiation Applicated to COVID-19
Pharmacokinetics of Antibiotics During Extracorporeal Membrane Oxygenation (ECMO) Support
Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 52